Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient

US9468598B2 · kind B2 · utility

Assignee

• ASTRAZENECA AB · SE

Inventors

• Rango Dietrich · Konstanz, DE
• Klaus Eistetter · Konstanz, DE
• Hartmut Ney · Konstanz, DE

Key dates

• Filing date: Apr 30, 2013
• Grant date: Oct 18, 2016
• Expiry date: Apr 30, 2033

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.